Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

New imaging techniques can assess and track changes in mouse acne without harm, aiding treatment choices.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Early diagnosis and lifelong zinc supplementation are crucial for treating acrodermatitis enteropathica effectively.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Histone modification is key in treating chronic inflammatory skin diseases.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Hidradenitis suppurativa is a skin condition possibly caused by hair follicle issues, with treatments focusing on infection and inflammation.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.